Breaking News

RK Pharma to Receive $200M Investment from PAG

To help ensure that RK Pharma can accelerate growth plans, partnerships, and develop/launch further innovative medicines.

RK Pharma Inc, a vertically integrated pharmaceutical company, will receive an investment of $200 million from PAG, a global investment firm. RK Pharma is engaged in the development, manufacture and sale of affordable generic pharmaceutical products with a particular focus on complex injectables. RK Pharma has a sterile drug product manufacturing facility in Pearl River, NY. RK Pharma group of companies include subsidiaries Apicore, Archis Pharma and Aktinos Pharma. Apicore and Aktinos provid...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters